National Planning Corporation’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-14,038
Closed -$1.14M 253
2017
Q3
$1.14M Sell
14,038
-3,365
-19% -$257K 0.09% 214
2017
Q2
$1.23M Sell
17,403
-5,403
-24% -$360K 0.09% 230
2017
Q1
$1.53M Sell
22,806
-3,329
-13% -$234K 0.12% 188
2016
Q4
$1.89M Buy
26,135
+6,501
+33% +$483K 0.15% 148
2016
Q3
$1.45M Sell
19,634
-2,145
-10% -$174K 0.12% 187
2016
Q2
$1.73M Sell
21,779
-431
-2% -$38.3K 0.13% 166
2016
Q1
$1.88M Sell
22,210
-8,663
-28% -$781K 0.16% 141
2015
Q4
$2.63M Buy
30,873
+9,778
+46% +$1.02M 0.22% 103
2015
Q3
$2.3M Buy
21,095
+1,954
+10% +$217K 0.21% 105
2015
Q2
$2.21M Buy
19,141
+1,521
+9% +$166K 0.2% 110
2015
Q1
$1.81M Sell
17,620
-11,605
-40% -$1.18M 0.16% 132
2014
Q4
$2.91M Sell
29,225
-8,261
-22% -$854K 0.21% 88
2014
Q3
$3.99M Buy
37,486
+2,624
+8% +$257K 0.3% 66
2014
Q2
$2.89M Buy
34,862
+1,846
+6% +$144K 0.23% 86
2014
Q1
$2.44M Buy
33,016
+161
+0.5% +$12.6K 0.21% 96
2013
Q4
$2.49M Buy
32,855
+7,269
+28% +$506K 0.22% 103
2013
Q3
$1.61M Buy
25,586
+5,350
+26% +$320K 0.16% 146
2013
Q2
$1.04M Buy
+20,236
New +$1.05M 0.13% 171

Other funds holding GILD

National Planning Corporation's GILD Position: Q4 2017 in Review

National Planning Corporation sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 14,038 shares — an estimated $1.14M sold.

National Planning Corporation first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $3.99M in Q3 2014. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • National Planning Corporation reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 14,038 Gilead Sciences shares in Q4 2017, an estimated $1.14M.
  • National Planning Corporation first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Gilead Sciences position peaked at $3.99M in Q3 2014.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.